Bill
S 748
Overview: S 748, a bill to make technical changes to certain provisions requiring epinephrine auto-injector devices to be made available in places of public assembly, was substitut
Overview: S 748, a bill to make technical changes to certain provisions requiring epinephrine auto-injector devices to be made available in places of public assembly, was substituted by A692.
Purpose and Intent: The bill aims to clarify and update the requirements for making epinephrine auto-injectors available in public places, such as schools, restaurants, and other venues, to improve access and preparedness for anaphylactic emergencies.
Key Provisions:
- Expands the definition of "places of public assembly" to include additional types of facilities and events
- Requires the development of standardized training and protocols for the use of epinephrine auto-injectors in public settings
- Provides liability protections for individuals and organizations that acquire and use epinephrine auto-injectors in good faith
Affected Parties and Impacts: The bill would impact individuals with severe allergies, as well as the owners and operators of public venues, by ensuring greater availability and proper use of epinephrine auto-injectors to respond to anaphylactic reactions.
Procedural and Timeline Considerations: The original S 748 bill has been substituted by A692, which is currently moving through the legislative process.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
